Komfo Anokye Teaching Hospital
Kumasi, Ashanti Region, Ghana
Location status: Recruiting
NCT Number: NCT07100561
In Ghana, about 88.3 per cent of cardiac admissions are due to Heart failure, making it the leading cause of admission due to heart conditions. Despite improved knowledge on heart failure and an increasing array of evidence-based guideline treatment options, there is still a significant readmission rate worldwide. This may be due to the underutilization of these evidence-based therapies or a lack of proper follow-up on these patients. Recurrent hospital admission is an independent predictor of death in heart failure. Strategies aimed at providing increased support at discharge and effective follow-up may be associated with lower readmission risk. This study aims to assess the effect of extensive post-discharge counselling and effective phone-based follow-up on the 30-day and 90-day heart failure readmission rate at a tertiary hospital in Ghana. This is a single-centre, pilot randomised controlled trial of heart failure patients admitted to the Komfo Anokye Teaching Hospital
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Kumasi, Ashanti Region, Ghana
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Counselling by their attending physicians plus Extensive post-discharge counselling from a study doctor/pharmacist/a trained nurse and telephone follow-ups in addition to their normal outpatient reviews. The telephone follow-ups will be weekly for the first 30 days and then 4 weekly till day 90.
Time frame: 90 days
30-day and 90-day heart failure readmissions between the intervention group and the control group.
Contact information is provided by the study sponsor or research team.
Komfo Anokye Teaching Hospital
Other
Extensive Post-discharge Counselling and Phone-based Follow-up Intervention to Reduce Heart Failure Readmission- A Pilot Randomized Control Trial
Acronym: HeFRA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03238690
Cardiovascular Diseases, Heart Diseases
Salt Lake City, Utah, United States
View Trial DetailsNCT07220798
Behavior, Behavioral Symptoms
New York, United States
View Trial DetailsNCT07420907
Aortic Stenosis, Aortic Stenosis Disease
Chicago, Illinois, United States
View Trial DetailsNCT07556588
Cardiovascular Diseases, Heart Diseases
Leuven, Belgium
View Trial Details